Genetic Signatures (ASX:GSS) Total Stockholders Equity : A$40.50 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Total Stockholders Equity?

Genetic Signatures's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$40.50 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Genetic Signatures's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.22. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Genetic Signatures's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Genetic Signatures Total Stockholders Equity Historical Data

The historical data trend for Genetic Signatures's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Total Stockholders Equity Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

10.57

45.93

49.34

54.80

42.91

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial													54.96	54.80	49.08	42.91	40.50

Genetic Signatures (ASX:GSS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Genetic Signatures's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(40.501	-	0)	/	186.483
	=	0.22

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Genetic Signatures's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.012	+	0)	/	40.501
	=	0.00

Genetic Signatures Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.